COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
07/03/2024
Data support ongoing development program of novel CDK2/9 inhibitor fadraciclib in patients with solid tumors and lymphoma BERKELEY HEIGHTS, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ [...]
Accumulus Synergy accueille deux cadres de stature internationale dans son équipe de direction
07/03/2024
BURLINGAME, Californie, 07 mars 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (« Accumulus ») a annoncé, ce jour, la nomination de Chanille Juneau au poste de Cheffe de produit, et du Dr Kevin Charest à celui de [...]
Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team
07/03/2024
BURLINGAME, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”) today announced the appointment of Chanille Juneau, Chief Product Officer, and Dr. Kevin Charest, Chief Information Security [...]
Lakeland Regional Health Residents Shine at Annual Promise Run 2024
07/03/2024
“Dr. Lyudmila Sarder, Resident Physician, Honors Late Mother in Emotional 5k Fundraiser to Conquer Cancer at the Annual Hollis Cancer Center Promise Run” Lakeland, FL, March 07, 2024 (GLOBE NEWSWIRE) -- Residents from [...]
Nanoflex Robotics Installs First Remote-Ready Robotics System in North America for Vascular Interventions
07/03/2024
The remote-ready robotics system, designed to be used for vascular interventions, was installed in The Jacobs Institute’s testing facility located within the University at Buffalo’s Canon Stroke and Vascular Research [...]
Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
07/03/2024
PARIS, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the first commercial doses of PYLCLARI ® have been sold in Italy. PYLCLARI ® (INN: Piflufolastat ( 18 F)) also [...]
AIM ImmunoTech Announces Launch of CEO Corner Platform
07/03/2024
CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties the ability to ask questions and submit topics for future videos Access the [...]
Teladoc Health Expands Obesity & Weight Management Capabilities
07/03/2024
Personalized health and medical care program built to improve weight related care and reduce the chronic disease complications of obesity in a single integrated experience PURCHASE, NY, March 07, 2024 (GLOBE NEWSWIRE [...]
Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
07/03/2024
BOSTON and ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to [...]
TOMI Expands SteraMist iHP Corporate Service Contracts and Clients
07/03/2024
Company announces new partners including The University of Texas and Rising Pharmaceuticals FREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global [...]
Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference
07/03/2024
Together with its partner, Frontage Laboratories, Telomir’s poster focused on pre-clinical data demonstrating Telomir-1’s ability to elongate telomere caps on human stem cells, targeting age-related inflammatory [...]
Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023
07/03/2024
Estimates Sequential Reduction in the Fourth Quarter of 2023 Operating Loss by Over $3.3 Million or Approximately 30% Compared to the Third Quarter of 2023 Achieves Record Backlog of $9.3 Million DURHAM, N.C., March 07 [...]
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
07/03/2024
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]
Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments
07/03/2024
Jodi Bryant joins as President, Healthcare, Matt Moran as Chief Strategy Officer, and Cody Fair elevated to Chief Commercial Officer NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare [...]
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
07/03/2024
Launched VOQUEZNA® (vonoprazan) tablets in November 2023 for the treatment of Erosive GERD (gastroesophageal reflux disease), achieving net revenues of $0.7 million for the fourth quarter Early physician prescribing [...]
Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
07/03/2024
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory [...]
Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
07/03/2024
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the [...]
Orchestra BioMed to Participate in Upcoming Investor Conferences
07/03/2024
NEW HOPE, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy
07/03/2024
Data support evaluation of the effects of two weeks of TNX-102 SL therapy on severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) and PTSD after civilian motor vehicle collision in [...]

Pages